E-learning: Reporting adverse drug reactions (ADRs)
This MedSafetyWeek (7-13 November 2022) take the opportunity to learn more about reporting adverse drug reactions (ADRs) through the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme.
The MHRA has created a new e-learning modules for doctors to learn about the importance of reporting suspected adverse drug reactions (ADRs).
The European Accreditation Council for Continuing Medical Education (EACCME), part of the European Union of Medical Specialists (UEMS), has given the module the highest order of accreditation. Doctors are awarded one EACCME credit (one hour CPD) on completion of the 45-minute ADR e-learning module.
Adverse Drug Reactions: reporting makes medicines safer
The Nursing Times, in close collaboration with MHRA, have developed an e-learning module for nurses. The module is free once you have registered and counts for two hours continuing professional development (CPD) credits. Find out more about the Yellow Card scheme by visiting yellowcard.mhra.gov.uk
The Centre for Postgraduate Pharmacy Education (CPPE) has developed a series of three e-learning programmes with the Wales Centre for Pharmacy Professional Education and MHRA. The programme has been endorsed by the Drug Safety Research Unit. The e-learning modules should help pharmacists understand how to identify, report and prevent ADRS.
Adverse drug reactions and medicines safety
Reporting adverse drug reactions